glp 1 and alcohol use disorder GLP-1 Anti-Obesity Rx and Substance Disorders GLP-1 Receptor Agonists and Research

These findings help address ongoing safety concerns surrounding this widely prescribed class of medications

doi: 10.1152/ajpendo.00302.2003

The Mayo Clinic has reported that the "sooner treatment starts, the better the chances for recovery." For patients like Schumer, weight loss is typically not the main goal, Balazs noted, but it is a "critical sign" of successful treatment

GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting

465 Impaired GLP-1 secretion or reduced GLP-1R expression may result in aberrantly heightened sympathetic excitation

Reimbursement for obesity-focused GLP-1 therapies remains inconsistent, particularly for oral formulations indicated for obesity management